We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$57.2B
AUM Growth
+$551M
Cap. Flow
-$331M
Cap. Flow %
-0.58%
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 29.09%
2 Healthcare 13.87%
3 Financials 11.48%
4 Consumer Discretionary 10.65%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BJ icon
726
BJs Wholesale Club
BJ
$12.3B
$4.47M 0.01%
+50,000
New +$4.52M
CDMO
727
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$4.41M 0.01%
+357,041
New +$4.09M
RVTY icon
728
Revvity
RVTY
$12.8B
$4.32M 0.01%
38,688
-27,600
-42% -$3.24M
CUBE icon
729
CubeSmart
CUBE
$9.45B
$4.29M 0.01%
+100,000
New +$4.79M
KPTI icon
730
Karyopharm Therapeutics
KPTI
$43.3M
$4.27M 0.01%
421,323
+133,334
+46% +$1.61M
NPWR icon
731
NET Power
NPWR
$134M
$4.24M 0.01%
400,000
-200,000
-33% -$1.96M
ICLR icon
732
Icon
ICLR
$12.6B
$4.13M 0.01%
+19,677
New +$4.59M
TPG icon
733
TPG
TPG
$7.69B
$4.08M 0.01%
+65,000
New +$4.27M
PEB icon
734
Pebblebrook Hotel Trust
PEB
$2.15B
$4.07M 0.01%
300,000
-50,000
-14% -$661K
ORIC icon
735
Oric Pharmaceuticals
ORIC
$1.34B
$4.04M 0.01%
500,000
-75,000
-13% -$688K
VALE icon
736
Vale
VALE
$63.6B
$3.99M 0.01%
+450,000
New +$4.58M
VCEL icon
737
Vericel Corp
VCEL
$2.32B
$3.94M 0.01%
+71,800
New +$3.63M
DNTH icon
738
Dianthus Therapeutics
DNTH
$6.29B
$3.92M 0.01%
+180,000
New +$4.63M
KRP icon
739
Kimbell Royalty Partners
KRP
$1.44B
$3.9M 0.01%
240,000
+20,000
+9% +$321K
RGNX icon
740
Regenxbio
RGNX
$672M
$3.87M 0.01%
+500,000
New +$4.69M
AKAM icon
741
Akamai
AKAM
$17.9B
$3.86M 0.01%
40,400
-77,400
-66% -$7.59M
TWLO icon
742
Twilio
TWLO
$29.5B
$3.78M 0.01%
+35,000
New +$3.2M
HRL icon
743
Hormel Foods
HRL
$13.9B
$3.75M 0.01%
119,546
-154,400
-56% -$4.84M
GL icon
744
Globe Life
GL
$14.3B
$3.72M 0.01%
33,400
-21,300
-39% -$2.3M
STRO icon
745
Sutro Biopharma
STRO
$416M
$3.68M 0.01%
200,000
-25,013
-11% -$764K
ATYR
746
aTyr Pharma
ATYR
$51.9M
$3.62M 0.01%
1,000,000
EPRT icon
747
Essential Properties Realty Trust
EPRT
$6.65B
$3.6M 0.01%
115,000
-35,000
-23% -$1.15M
AMH icon
748
American Homes 4 Rent
AMH
$12.4B
$3.59M 0.01%
+95,928
New +$3.59M
GKOS icon
749
Glaukos
GKOS
$10.1B
$3.51M 0.01%
23,398
-150,000
-87% -$20.7M
AVNT icon
750
Avient
AVNT
$3.48B
$3.47M 0.01%
+85,000
New +$4.12M

Similar funds

Adage Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
  • Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
  • Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
  • Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
  • Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
  • Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
  • Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.

Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.